[go: up one dir, main page]

MX2010003202A - Metodo para producir virus de la gripe. - Google Patents

Metodo para producir virus de la gripe.

Info

Publication number
MX2010003202A
MX2010003202A MX2010003202A MX2010003202A MX2010003202A MX 2010003202 A MX2010003202 A MX 2010003202A MX 2010003202 A MX2010003202 A MX 2010003202A MX 2010003202 A MX2010003202 A MX 2010003202A MX 2010003202 A MX2010003202 A MX 2010003202A
Authority
MX
Mexico
Prior art keywords
virus
flu virus
flu
producing
collecting
Prior art date
Application number
MX2010003202A
Other languages
English (en)
Inventor
Catherine Gerdil
Catherine Moste
Isabelle Legastelois
Michel Bublot
Fran Ois-Xavier Le Gros
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of MX2010003202A publication Critical patent/MX2010003202A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invenci?n se relaciona a un m?todo para producir el virus de la gripe, que comprende: a) administrar una vacuna de la gripe a gallinas; b) recolectar los huevos de las gallinas vacunadas; c) activar el proceso de embriog?nesis; d) infectar los huevos embrionados al inocular un virus de la gripe en la cavidad alantoica; e) incubar los huevos embrionados infectados en condiciones de temperatura y humedad que permiten la replicaci?n del virus; y f) recolectar el l?quido alantoico que contiene el virus.
MX2010003202A 2007-09-26 2008-09-26 Metodo para producir virus de la gripe. MX2010003202A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0757884A FR2921387B1 (fr) 2007-09-26 2007-09-26 Procede de production du virus de la grippe
PCT/FR2008/051730 WO2009050390A2 (fr) 2007-09-26 2008-09-26 Procede de production du virus de la grippe

Publications (1)

Publication Number Publication Date
MX2010003202A true MX2010003202A (es) 2010-04-09

Family

ID=39146849

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003202A MX2010003202A (es) 2007-09-26 2008-09-26 Metodo para producir virus de la gripe.

Country Status (17)

Country Link
US (2) US7871807B2 (es)
EP (1) EP2195420B1 (es)
JP (1) JP5537429B2 (es)
KR (1) KR101744014B1 (es)
CN (1) CN101809144B (es)
AR (1) AR068541A1 (es)
AU (1) AU2008313576B2 (es)
BR (1) BRPI0817247A2 (es)
CA (1) CA2700288C (es)
ES (1) ES2541551T3 (es)
FR (1) FR2921387B1 (es)
IL (1) IL204361A (es)
MX (1) MX2010003202A (es)
RU (1) RU2484136C2 (es)
TW (1) TWI485247B (es)
WO (1) WO2009050390A2 (es)
ZA (1) ZA201001480B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
EP2318832B1 (en) 2008-07-15 2013-10-09 Academia Sinica Glycan arrays on ptfe-like aluminum coated glass slides and related methods
US20140205619A1 (en) * 2008-11-28 2014-07-24 Biolex Therapeutics, Inc. Recombinant avian influenza vaccine and uses thereof
US20140205993A1 (en) * 2013-01-18 2014-07-24 Biolex Therapeutics, Inc. Recombinant avian influenza vaccine and uses thereof
JP2012521786A (ja) 2009-03-30 2012-09-20 モウント シナイ スクール オフ メディシネ インフルエンザウイルスワクチン及びその使用
EP2435475B1 (en) 2009-05-26 2018-10-17 Icahn School of Medicine at Mount Sinai Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
KR20120132506A (ko) 2010-02-18 2012-12-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 질환의 예방 및 치료에 사용되는 백신
JP2013526849A (ja) 2010-03-30 2013-06-27 モウント シナイ スクール オフ メディシネ インフルエンザウイルスワクチン及びその使用
WO2011130332A1 (en) * 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
SG11201400743VA (en) 2011-09-20 2014-04-28 Sinai School Medicine Influenza virus vaccines and uses thereof
CN102586194B (zh) * 2011-12-01 2013-08-14 哈药集团生物疫苗有限公司 H9亚型禽流感病毒Vero细胞适应株及其应用
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
EP4154907A1 (en) 2012-12-18 2023-03-29 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
US9782476B2 (en) 2013-09-06 2017-10-10 Academia Sinica Human iNKT cell activation using glycolipids with altered glycosyl groups
CN103736088B (zh) * 2013-11-08 2015-07-15 广东大华农动物保健品股份有限公司 一种禽流感h9亚型灭活疫苗及其制备方法和应用
CN106459920B (zh) 2014-01-16 2020-10-30 中央研究院 治疗及检测癌症的组合物及方法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TWI797430B (zh) 2014-03-27 2023-04-01 中央研究院 反應性標記化合物及其用途
TWI717319B (zh) 2014-05-27 2021-02-01 中央研究院 得自類桿菌屬之岩藻糖苷酶及其用途
AU2015267047A1 (en) 2014-05-27 2017-01-05 Academia Sinica Anti-CD20 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CA2950440A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-her2 glycoantibodies and uses thereof
KR102494193B1 (ko) 2014-05-28 2023-01-31 아카데미아 시니카 항-ｔｎｆ-알파 글리코항체 및 이의 용도
JP6899321B2 (ja) 2014-09-08 2021-07-07 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 糖脂質を使用するヒトｉＮＫＴ細胞活性化
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
AU2016209032A1 (en) 2015-01-23 2017-08-10 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
KR102691114B1 (ko) 2015-01-24 2024-08-01 아카데미아 시니카 신규한 글리칸 콘주게이트 및 이를 사용하는 방법
AU2017231749A1 (en) 2016-03-08 2018-09-20 Academia Sinica Methods for modular synthesis of N-glycans and arrays thereof
EP3471767A4 (en) 2016-06-15 2020-01-15 Icahn School of Medicine at Mount Sinai INFLUENZA VIRUS HEMAGGLUTININS AND USES THEREOF
KR101879936B1 (ko) * 2016-06-17 2018-07-19 건국대학교 산학협력단 신규한 조류 인플루엔자 h5n9 재조합 바이러스 및 이를 포함하는 백신 조성물
KR102588027B1 (ko) 2016-08-22 2023-10-12 초 파마 인크. 항체, 결합 단편 및 사용 방법
JOP20190088A1 (ar) * 2016-10-21 2019-04-21 Us Agriculture نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
CN108653724B (zh) * 2017-04-01 2020-11-27 普莱柯生物工程股份有限公司 一种用于预防禽减蛋综合征的疫苗组合物、及其制备方法和应用
EP3606555A4 (en) 2017-04-07 2021-08-04 Icahn School of Medicine at Mount Sinai INFLUENZA VIRUS TYPE B ANTI-NEURAMINIDASE ANTIBODIES AND THEIR USES
JP7084627B2 (ja) * 2018-06-06 2022-06-15 株式会社マナＨｓコーポレーション ウイルス感染症予防用組成物
JPWO2021107013A1 (es) * 2019-11-29 2021-06-03
CN114184797B (zh) * 2021-12-06 2024-06-14 辽宁成大生物股份有限公司 一种流感病毒裂解疫苗单价原液血凝素的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1535543A1 (ru) * 1988-04-05 1990-01-15 Всесоюзный научно-исследовательский институт гриппа Способ получени гриппозного диагностикума
RU2080124C1 (ru) * 1995-10-19 1997-05-27 Санкт-Петербургский научно-исследовательский институт вакцин и сывороток Способ получения живой гриппозной вакцины
EP0848956A1 (en) 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo vaccination against Newcastle Disease
US6682754B2 (en) * 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
DE10133664A1 (de) * 2001-07-11 2003-02-06 Henkel Kgaa Verfahren zur Untersuchung von dermalen Klebstoffabrissen
RU2290205C1 (ru) * 2005-09-13 2006-12-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунологическим препаратам "МИКРОГЕН" Министерства здравоохранения Российской Федерации Способ получения живой вакцины для профилактики гриппа

Also Published As

Publication number Publication date
FR2921387B1 (fr) 2012-04-20
JP5537429B2 (ja) 2014-07-02
KR101744014B1 (ko) 2017-07-04
TW200923093A (en) 2009-06-01
TWI485247B (zh) 2015-05-21
WO2009050390A3 (fr) 2009-06-11
US7871807B2 (en) 2011-01-18
WO2009050390A2 (fr) 2009-04-23
US20110212129A1 (en) 2011-09-01
IL204361A (en) 2013-06-27
CN101809144A (zh) 2010-08-18
AR068541A1 (es) 2009-11-18
CA2700288A1 (en) 2009-04-23
RU2010116187A (ru) 2011-11-10
KR20100090241A (ko) 2010-08-13
ZA201001480B (en) 2011-05-25
JP2010539918A (ja) 2010-12-24
AU2008313576A1 (en) 2009-04-23
CA2700288C (en) 2019-11-12
EP2195420B1 (fr) 2015-04-08
RU2484136C2 (ru) 2013-06-10
BRPI0817247A2 (pt) 2015-06-16
US20090081255A1 (en) 2009-03-26
ES2541551T3 (es) 2015-07-21
EP2195420A2 (fr) 2010-06-16
CN101809144B (zh) 2013-12-25
FR2921387A1 (fr) 2009-03-27
AU2008313576B2 (en) 2014-01-23

Similar Documents

Publication Publication Date Title
MX2010003202A (es) Metodo para producir virus de la gripe.
Chen et al. Advances in development and application of influenza vaccines
Wong et al. Traditional and new influenza vaccines
JP2021078505A (ja) インフルエンザウイルスワクチン及びその使用
CN107949636B (zh) 活减毒病毒以及生产和使用方法
WO2010101663A3 (en) Live attenuated influenza virus vaccines comprising microrna response elements
EA200970271A1 (ru) Получение вакцин против вируса гриппа без использования куриных эмбрионов
AU2012306866A1 (en) Recombinant influenza virus highly expressing HA protein and preparation method and use thereof
US10548965B2 (en) Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian H5N1 influenza
MX2014000753A (es) Procedimiento para producir antigeno viral y vacunas.
Lee et al. Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use
Tian et al. Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam
MX376138B (es) Produccion de particulas similares a virus de influenza en plantas.
Schotsaert et al. Influenza vaccines: a moving interdisciplinary field
EP2486791A4 (en) PROTEIN VACCINE PREVENTED FROM TRANSGENIC PLANTS AGAINST HIGH DENSITY PATHOGENIC BIRD VEGETABLE VIRUSES AND MANUFACTURING METHOD THEREFOR
NZ622731A (en) Increasing virus-like particle yield in plants
Ninyio et al. Virus-like particle vaccines: A prospective panacea against an avian influenza panzootic
Blanco-Lobo et al. A bivalent live-attenuated vaccine for the prevention of equine influenza virus
Chu et al. Respiratory viruses and virus-like particle vaccine development: how far have we advanced?
WO2010028072A3 (en) Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use
RU2012130551A (ru) Штамм вируса гриппа а/17/виктория/2011/89 (h3n2) для производства живой гриппозной интраназальной вакцины для взрослых и для детей
RU2017110225A (ru) Способ получения вакцинных антигенов, получаемые вакцинные антигены и их применение
ATE508185T1 (de) Virosomenpartikel mit antigenen aus influenzavirus und hepatitis-b-virus
Ruan et al. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs
CU20150019A7 (es) Rotavirus humanos modificados

Legal Events

Date Code Title Description
FG Grant or registration